Gopal Pawar

Dr. Gopal Pawar


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2016 in Toxicology and Applied Pharmacology
Verified
Journal Article
Closed access
Mohamed A. AbdallahMohamed A. Abdallah
Mohamed A. Abdallah
GPGopal Pawar
Gopal Pawar
SHStuart Harrad
Stuart Harrad

1 February 2019 in Regulatory Toxicology and Pharmacology
Verified
Journal Article
Open access
CMC.L. Mellor
C.L. Mellor
RRR.L. Marchese Robinson
R.L. Marchese Robinson
RBR. Benigni
R. Benigni
DED. Ebbrell
D. Ebbrell
SES.J. Enoch
S.J. Enoch
MCMark Cronin
Mark Cronin
Computational approaches are increasingly used to predict toxicity due, in part, to pressures to find alternatives to animal testing. Read-across is the "new paradigm" which aims to predict toxicity by identifying similar, data rich, source compounds. This assumes that similar molecules tend to exhibit similar activities i.e. molecular similarity is integral to read-across. Various of molecular fingerprints and similarity measures may be used to calculate molecular similarity. This study investigated the value and concordance of the Tanimoto similarity values calculated using six widely used fingerprints within six toxicological datasets. There was considerable variability in the similarity values calculated from the various molecular fingerprints for diverse compounds, although they were reasonably concordant for homologous series acting via a common mechanism. The results suggest generic fingerprint-derived similarities are likely to be optimally predictive for local datasets, i.e. following sub-categorisation. Thus, for read-across, generic fingerprint-derived similarities are likely to be most predictive after chemicals are placed into categories (or groups), then similarity is calculated within those categories, rather than for a whole chemically diverse dataset.

1 January 2015 in Environment International
Verified
Journal Article
Closed access
Mohamed A. AbdallahMohamed A. Abdallah
Mohamed A. Abdallah
GPGopal Pawar
Gopal Pawar
SHStuart Harrad
Stuart Harrad

6 January 2016 in Journal of Exposure Science & Environmental Epidemiology
Verified
Journal Article
Closed access
GPGopal Pawar
Gopal Pawar
MAMohamed Abou-Elwafa Abdallah
Mohamed Abou-Elwafa Abdallah
ESEugenia Villaverde de Sáa
Eugenia Villaverde de Sáa
SHStuart Harrad
Stuart Harrad

24 August 2015 in Environmental Science & Technology
Verified
Journal Article
Open access
MAMohamed Abou-Elwafa Abdallah
Mohamed Abou-Elwafa Abdallah
GPGopal Pawar
Gopal Pawar
SHStuart Harrad
Stuart Harrad
Human dermal absorption of eight mono- to deca-brominated diphenyl ethers (PBDEs) was investigated for the first time using EPISKIN human skin equivalent tissue. Using a standard in vitro protocol, EPISKIN tissues mounted in specially designed diffusion cells were exposed to the target PBDEs for 24 h. Estimated steady-state flux (Jss) and permeation coefficients (Papp) across the skin increased with decreasing bromine substitution from BDE-153 (Papp = 4.0 × 10–4 cm/h) to BDE-1 (Papp = 1.1 × 10–2 cm/h). This was accompanied by an increase in the time required to traverse the skin tissue into the receptor fluid (lag time) from 0.25 h for BDE-1 to 1.26 h for BDE-153. Papp values for the studied PBDEs were correlated significantly (P < 0.05) with physicochemical parameters like water solubility and log KOW. While less brominated congeners achieved faster dermal penetration, higher PBDEs displayed greater accumulation within the skin tissue. The PBDEs thus accumulated represent a contaminant depot from which they may be slowly released to the systemic circulation over a prolonged period. Maximal percutaneous penetration was observed for BDE-1 (∼30% of the applied 500 ng/cm2 dose). Interestingly, BDE-183 and BDE-209 showed very low dermal absorption, exemplified by a failure to reach the steady state within the 24 h exposure period that was studied.

11 June 2019 in Frontiers in Pharmacology
Verified
Journal Article
Open access
PDF file
GPGopal Pawar
Gopal Pawar
JMJudith C. Madden
Judith C. Madden
DEDavid Ebbrell
David Ebbrell
JFJames W. Firman
James W. Firman
MCMark Cronin
Mark Cronin
A plethora of databases exist online that can assist in in silico chemical or drug safety assessment. However, a systematic review and grouping of databases, based on purpose and information content, consolidated in a single source, has been lacking. To resolve this issue, this review provides a comprehensive listing of the key in silico data resources relevant to: chemical identity and properties, drug action, toxicology (including nano-material toxicity), exposure, omics, pathways, Absorption, Distribution, Metabolism and Elimination (ADME) properties, clinical trials, pharmacovigilance, patents-related databases, biological (genes, enzymes, proteins, other macromolecules etc.) databases, protein-protein interactions (PPIs), environmental exposure related, and finally databases relating to animal alternatives in support of 3Rs policies. More than nine hundred databases were identified and reviewed against criteria relating to accessibility, data coverage, interoperability or application programming interface (API), appropriate identifiers, types of in vitro, in vivo,-clinical or other data recorded and suitability for modelling, read-across, or similarity searching. This review also specifically addresses the need for solutions for mapping and integration of databases into a common platform for better translatability of preclinical data to clinical data.